GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Amarantus Bioscience Holdings AMBS · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 4 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Amarantus Bioscience Holdings — daily AMBS Delayed
Market value
$631
Last close × shares
Volume
134
Shares, 4 Nov 2026

About Amarantus Bioscience Holdings

Its shares trade under the ticker AMBS. It has been listed since 29 September 2008. In the fiscal year to 31 December 2022, it reported revenue of $95,331 and a net loss of $4.8m. At that date it held total assets of $10.2m and shareholders' equity of −$24.7m.

Amarantus BioScience Holdings, Inc. is a biopharmaceutical company. The company is headquartered in San Francisco, California. The company went IPO on 2008-09-29. The firm has approximately three operating divisions: the diagnostics division, the therapeutics division and the drug discovery division. The company owns licenses to various product candidates in the therapeutic and diagnostic sectors of the life sciences industry. The company is developing diagnostic product candidates in the field of neurology, and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology and regenerative medicine. The Company, through its subsidiary, Cutanogen Corporation, is developing a regenerative medicine cell therapy-based autologous skin replacement product, Engineered Skin substitute, which is in mid-stage clinical development, for the treatment of life-threatening severe burns. The company is also developing a mid-stage clinical-stage pharmaceutical drug candidate, Eltoprazine, a small molecule 5HT1a/1b partial agonist for the treatment of symptomatic neurological disorders.

Figures and description from our data supplier, not checked against the company's own report.

More about Amarantus Bioscience Holdings →

Latest on Amarantus Bioscience Holdings

Our reporting

We have not reported on Amarantus Bioscience Holdings yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Amarantus Bioscience Holdings's ticker?

Amarantus Bioscience Holdings trades as AMBS on its US listing, under ISIN US02300U2050.

What was Amarantus Bioscience Holdings's last closing price?

0.00 on 4 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.